An important facet of the Michigan Comprehensive Diabetes Center (MCDC) is its ground-breaking clinical research. Through clinical studies, our doctors and research staff learn more about diabetes and its complications, while investigating new methodologies and treatments. We are proud to be on the front line of diabetes research with funding from the top agencies, such as the American Diabetes Association, the National Institutes of Health, and the Juvenile Diabetes Research Foundation. The goals of our research are to revolutionize patient care, improve quality of life, and — ultimately — to find a cure.
Many of the MCDC's innovative studies are making an impact today and have transformed the field of diabetes knowledge and treatment. This would not be possible without study participants, who are our partners in the vital research that we perform. If you, or someone you know, would be interested in helping contribute to medical advances in diabetes, please go to the categories below to read about our current clinical studies.
OUR CURRENT CLINICAL STUDIES Seeking Participants:
Learn about the Preventing Early Renal Loss (PERL) Study for Type 1 Diabetes: